{"changes":[],"country":"US","description":"AAV gene therapy biotech focused on diseases of the neuromuscular junction. Targets pharma partners and patients with congenital myasthenic syndromes and related rare neuromuscular disorders. Differentiates with leads AMP-101 (Dok-7) and AMP-201 (Collagen-Q) and a tightly-focused indication scope advised by NMJ experts.","domain":"amplobiotechnology.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":39.396459,"lng":-76.614815,"location":"Towson, Maryland","name":"Amplo Biotechnology, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":2999358,"currency":"USD","date":"2024-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"amplobiotechnology-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"amplobiotechnology.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://amplobiotechnology.com"},{"fact":"description","publisher":"amplobiotechnology.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://amplobiotechnology.com"}],"stage":null,"techStack":["Cloudflare","Cloudflare Bot Management"],"totalRaisedUsd":3950000,"updatedAt":"2026-05-02"}